Main Article Content
and the current scenario of orphan drug legislations in India. An orphan drug is a pharmaceutical agent that is used to
treat a rare medical condition (viz., glioblastoma multiforme, nocardiosis, Tourette syndrome, etc). Developed countries
such as United States (US), Europe, Japan, and Australia have laid down legal framework for combating rare diseases. A path
breaking legislation was formulated by the US government way back in 1983, known as â€œOrphan Drugs Act (ODA).â€ The
key purpose of ODA was to incentivize R and D initiatives for such drugs to treat millions of population suffering from
â€œorphan diseases.â€ Though the percentage of patients suffering from â€œrare diseasesâ€ in India is reportedly higher than the
world average, unfortunately even today such cases get little help from our government. Indian government should also
encourage its domestic pharmaceutical industry to get engaged in research for orphan drugs by putting an â€œODAâ€ in place
and extending financial support, and regulatory concessions like smaller and shorter clinical trials, without further delay.
Thus, India could wellâ€‘demonstrate that the concept of orphan drugs for orphan diseases is really not orphan in India.
Key words: Orphan diseases, orphan drugs act, orphan drug
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
FDA. Available from: http://www.fda.gov/downloads/ForConsumers/
ConsumerUpdates/ucm107301.pdf. [Last accessed on 2013 Jul 20].
Tapray blog. Available from: http://www.tapanray. i n /
[Last accessed on 2013 May 10].
Pharma Express. The eternal orphan. Available from: http://www.
expresspharmaonline.com/20080831/research01.shtml. [Last accessed
on 2013 Apr 13]. (Accessed on April 2013)
Sharma A, Jacob A, Tandon M, Kumar D. Orphan drug: Development
trends and strategies. J Pharm Bioallied Sci 2010;2:290â€‘9.
Orphanet. Available from: http://www.orpha.net/consor/cgiâ€‘bin/
Education_AboutOrphanDrugs.php?lng=EN and stapage=ST_
[Last accessed on 2013 May 13].